Home > Analytics > DR LAL PATHLABS

DR LAL PATHLABS
Intrinsic Value | Fundamental Analysis

BOM : 539524     NSE : LALPATHLAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Feb 07,2023
Price(EOD): ₹ 1,917.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 15,989.03 Cr
Value of ₹ 1 Lac invested in DR LAL PATHLABS
on Feb 07,2018 (price: ₹ 875.05)

₹ 1 L

₹ 2.19 L

1W : -6.6% 1M : -13.8% 1Y : -36.7%
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results
DR LAL PATHLABS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
DR LAL PATHLABS -6.6% -13.8% -36.7%
APOLLO HOSPITALS ENTERPRISE 1.2% -1.7% -7.1%
MAX HEALTHCARE INSTITUTE -0.3% 1.6% 21.2%
FORTIS HEALTHCARE 0.1% -2% 3%
NARAYANA HRUDAYALAYA 2.6% 2.6% 12.6%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 0.5% -2.6% 6.8%
ASTER DM HEALTHCARE 1.2% -7% 14.4%
RAINBOW CHILDRENS MEDICARE 3.4% 0.8% NA
METROPOLIS HEALTHCARE -4.3% -6.1% -49.3%

FUNDAMENTAL ANALYSIS OF DR LAL PATHLABS

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 LALPATHLAB is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF DR LAL PATHLABS

 
Valuation Score
[As on : Feb 07,2023 ]

Ratio Consolidated
P/E
P/B
P/S
64.88
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 246.30 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

11.02
P/B Calculated based on Book Value of Rs 1,449.79 Cr
[Latest Year - Mar2022 - Consolidated Results ]

7.94
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,011.40 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF DR LAL PATHLABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-6%
-11%
-12%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF DR LAL PATHLABS



DR LAL PATHLABS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF DR LAL PATHLABS

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.24
0
0
0.08
0.24
0
0
0.08
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF DR LAL PATHLABS

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF DR LAL PATHLABS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-8.32%
-21.42%
-25.58%
-25.97%
-1.51%
3.48%
-6.13%
-7.9%
QtrlyTrend
-6
Latest Qtr: Dec2022
Quarterly Result Analysis →


DR LAL PATHLABS related INDICES

BSE Indices1W1M1Y
S&P BSE SMALLCAP SELECT INDEX 0.9% -1.4% -8.7%
S&P BSE 150 MIDCAP -0% -2.5% -1.3%
S&P BSE 250 LARGEMIDCAP -0.2% -3.2% -2.1%
S&P BSE 200 -0.3% -3.3% -1.9%
S&P BSE 500 -0.3% -3.2% -2.4%
NSE Indices1W1M1Y
NIFTY200 QUALITY30 0.2% -0.5% -3.4%
NIFTY MIDCAP150 QUALITY 50 0.2% -1% -9.1%
NIFTY MIDCAP150 0% -2.8% -0.5%
NIFTY FREE MIDCAP 100 -0% -3.2% -1%
NIFTY LARGE MIDCAP 250 -0.1% -3% -1.4%

You may also like the below Video Courses


FAQ about DR LAL PATHLABS


Is DR LAL PATHLABS good for long term investment?

As on Feb 07,2023, the Fundamentals of DR LAL PATHLABS look Strong and hence it may be good for long term investment! See Financial Performance of DR LAL PATHLABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DR LAL PATHLABS UnderValued or OverValued?

As on Feb 07,2023, DR LAL PATHLABS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of DR LAL PATHLABS ?

As on Feb 07,2023, the Intrinsic Value of DR LAL PATHLABS is Rs. 2,151.97 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,040.40
Fair Value [Median EV / Sales Model] : Rs. 2,151.97
Fair Value [Median Price / Sales Model] : Rs. 2,181.98
Estimated Median Fair Value of DR LAL PATHLABS : Rs. 2,151.97

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is DR LAL PATHLABS trading at a Premium or Discount?

As on Feb 07,2023, DR LAL PATHLABS is trading at a Discount of -11% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].